The Neutrophil/Lymphocyte Ratio and Outcomes in Hospitalized Patients with Community-Acquired Pneumonia: A Retrospective Cohort Study

Aysun Tekin,Felix W. Wireko,Ognjen Gajic,Yewande E. Odeyemi
DOI: https://doi.org/10.3390/biomedicines12020260
IF: 4.757
2024-01-24
Biomedicines
Abstract:We aimed to assess the prognostic role of the neutrophil/lymphocyte ratio (NLR) in community-acquired pneumonia (CAP) via a single-center retrospective cohort of hospitalized adult patients from 1/2009 to 12/2019. Patients were dichotomized into lower NLR (≤12) and higher NLR (>12). The primary outcome was mortality. ICU admission and hospital- and ICU-free days were secondary outcomes. The pneumonia severity index (PSI) and the NLR's ability to predict outcomes was also tested. An NLR ≤12 was observed in 2513 (62.2%) patients and >12 in 1526 (37.8%). After adjusting for PSI, the NLR was not associated with hospital mortality (odds ratio [OR] 1.115; 95% confidence interval [CI] 0.774, 1.606; p = 0.559), but it was associated with a higher risk of ICU admission (OR 1.405; 95% CI 1.216, 1.624; p < 0.001). The PSI demonstrated acceptable discrimination for mortality (area under the receiver operating characteristic curve [AUC] 0.78; 95% CI 0.75, 0.82) which was not improved by adding the NLR (AUC 0.78; 95% CI 0.75, 0.82, p = 0.4476). The PSI's performance in predicting ICU admission was also acceptable (AUC 0.75; 95% CI 0.74, 0.77) and improved by including the NLR (AUC 0.76, 95% CI 0.74, 0.77, p = 0.008), although with limited clinical significance. The NLR was not superior to the PSI for predicting mortality in hospitalized CAP patients.
biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to evaluate the prognostic role of the neutrophil - to - lymphocyte ratio (NLR) in hospitalized patients with community - acquired pneumonia (CAP). Specifically, the study aims to explore through a single - center retrospective cohort study whether NLR can effectively predict the in - hospital mortality, ICU admission rate and other clinical outcomes in CAP patients, such as the number of days requiring mechanical ventilation and supportive treatment. ### Research Background Community - acquired pneumonia (CAP) is an acute parenchymal lung infection and one of the leading causes of hospitalization and death in the United States, resulting in more than 1.5 million hospitalizations and approximately 100,000 deaths annually. Risk stratification and prognostic assessment are crucial for guiding the management of the disease. Although several prognostic tools have been evaluated for CAP, the most commonly used and validated tools include the Pneumonia Severity Index (PSI), CURB - 65 score and ATS/IDSA guidelines. In addition, some biomarkers such as NT - pro - BNP, C - reactive protein and procalcitonin have poor prognostic evaluation effects when used alone. NLR, as an easily measurable index, has gradually attracted attention for its prognostic value under various stress conditions (including infection). ### Research Objectives The main objective of this study is to evaluate the prognostic value of NLR in predicting the clinical outcomes of hospitalized CAP patients. Specific goals include: - Evaluating whether NLR can independently predict in - hospital mortality and 6 - month mortality. - Evaluating whether NLR can predict ICU admission rate and other secondary outcomes, such as the number of days requiring mechanical ventilation and supportive treatment. - Comparing the performance of NLR and PSI in predicting in - hospital mortality and ICU admission rate. ### Main Findings - **Primary Outcome**: There was no significant difference in in - hospital mortality between patients with NLR > 12 and those with NLR ≤ 12 (adjusted OR 1.115; 95% CI 0.774, 1.606; p = 0.559). However, the ICU admission rate was significantly increased in patients with NLR > 12 (adjusted OR 1.405; 95% CI 1.216, 1.624; p < 0.001). - **Secondary Outcome**: There was no significant difference in the number of days requiring mechanical ventilation and supportive treatment in patients with NLR > 12. When NLR was analyzed as a continuous variable, it was also only significantly associated with ICU admission rate and the number of days outside the hospital, but had no significant association with other secondary outcomes. - **Predictive Performance**: PSI showed good discriminatory ability in predicting in - hospital mortality (AUC 0.78; 95% CI 0.75, 0.82), and adding NLR did not significantly improve this predictive ability (AUC 0.78; 95% CI 0.75, 0.82; p = 0.4476). In predicting ICU admission rate, PSI also performed well (AUC 0.75; 95% CI 0.74, 0.77), and improved after adding NLR (AUC 0.76; 95% CI 0.74, 0.77; p = 0.008), but with limited clinical significance. ### Conclusion In hospitalized CAP patients, NLR > 12 is not related to in - hospital mortality, but is significantly related to ICU admission rate. The performance of NLR in predicting in - hospital mortality is inferior to that of PSI, and adding NLR does not significantly improve the predictive ability of PSI. Therefore, the clinical application value of NLR in CAP prognostic assessment is limited. Future studies need to further verify these findings and explore other potential biomarkers or combination methods to improve the accuracy of prognostic assessment.